cas 884494-34-2|| where to buy 2-ethynyl-5-fluoropyridine

Название продукции:2-ethynyl-5-fluoropyridine

IUPAC Name:2-ethynyl-5-fluoropyridine

Упаковочная единица	Доступно для заказа	Цена ($)
CM171185-1g	in stock	ưȎƞ
CM171185-5g	in stock	Ƅǯǯ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 884494-34-2 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:884494-34-2; Молекулярная формула:C7H4FN; Точка плавления:-; Smiles-код:FC1=CN=C(C#C)C=C1; Плотность:

: Номер в каталоге:CM171185; Молекулярная масса:121.11; Точка кипения:150.6°C at 760 mmHg; Номер Mdl:MFCD03095259; Хранение:Store at 2-8°C.

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Olutasidenib; Rigel announces publication of data on REZLIDHIA(Olutasidenib) in post-venetoclax patients with mutant IDH1 AML in Leukemia & Lymphoma.
REZLIDHIA (Olutasidenib), a potent, selective, oral, small-molecule inhibitor of mutant isocitrate dehydrogenase-1 (mIDH1), in patients with mIDH1 acute myeloid leukemia (AML) who were relapsed/refractory (R/R) to prior venetoclax-based regimens.